This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You Looking for a Top Momentum Pick? Why Tenet Healthcare (THC) is a Great Choice
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Tenet Healthcare (THC) Soars 69% YTD: More Room to Run?
by Zacks Equity Research
Banking high on a solid guidance and strategic measures, Tenet Healthcare (THC) holds enough potential to reap benefits for investors.
Zacks Industry Outlook Highlights: Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
Zacks Industry Outlook Highlights: Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems
3 Stocks to Watch as Hospital Industry Stages a Recovery
by Zacks Equity Research
Strategic buyouts, divestitures, better volumes and cost-cutting measures are expected to aid hospital companies like ACHC, THC and CYH.
Community Health (CYH) Soars 111% YTD: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) strategic initiatives are likely to boost its revenues, which in turn, might perk up its share price.
Ensign Group (ENSG) Boosts Washington Presence With Health Hubs
by Zacks Equity Research
Ensign Group (ENSG) acquires four skilled nursing facilities in Washington. The move intends to offer improved health outcomes across the state.
Encompass Health (EHC) Buys Frontier, Boosts Home Health Services
by Zacks Equity Research
Encompass Health (EHC) completes the purchase of Frontier, which reflects its efforts to offer enhanced care across several states.
Here's Why You Should Retain Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) is gaining from rise in revenues, several acquisitions and joint ventures as well as robust cash flows.
Encompass Health (EHC) Gains on Strong Revenues & Cash Flows
by Zacks Equity Research
Encompass Health (EHC) set to benefit on the back of consistent top-line growth, robust 2021 business outlook and strong liquidity stand.
HCA Healthcare (HCA) Ties Up for Accelerating Digital Processes
by Zacks Equity Research
HCA Healthcare (HCA) forms alliance with Google Cloud with an aim to speed up digital transformation of the former, resulting in enhanced clinical and operational processes.
5 Solid Reasons Why The Joint (JYNT) Looks Attractive Now
by Zacks Equity Research
The Joint Corp. 's (JYNT) resilient business model along with its long-term expansion plans makes it a perfect fit for your investment portfolio.
HCA Healthcare (HCA) to Rebrand Certain Units in Florida
by Zacks Equity Research
HCA Healthcare (HCA) to adopt the HCA Florida Healthcare brand to enhance its appeal and solidify its presence.
Why Is Tenet (THC) Up 13.1% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare (THC) Offers Senior Notes Worth $1.4 B
by Zacks Equity Research
Tenet Healthcare (THC) exhibits prudence by issuing notes to procure funds and pay down its existing debt.
Tenet (THC) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
HCA Healthcare (HCA) to Divest Hospital for Better Liquidity
by Zacks Equity Research
HCA Healthcare (HCA) to sell Redmond Regional Medical Center, GA to AdventHealth for boosting financial solvency.
Select Medical (SEM) Banks on Top-Line Growth, Solid Cash Flows
by Zacks Equity Research
Select Medical (SEM) gains from constant top-line growth, strong 2021 business outlook and solid cash balance.
MEDNAX's (MD) Q1 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q1 results reflect lower costs. However, the same is partly offset by softer revenues.
Select Medical (SEM) Beats on Q1 Earnings, Hikes '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) first-quarter results indicate uptick in revenues stemming from solid segmental performances except Outpatient Rehabilitation, partly offset by higher costs.
Ensign Group's (ENSG) Q1 Earnings Beat, 2021 EPS View Up
by Zacks Equity Research
Ensign Group's (ENSG) first-quarter results reflect better revenues and a solid performance of its Transitional and Skilled Services.
Top Ranked Momentum Stocks to Buy for April 30th
by Zacks Equity Research
CROX, BYD, THC, and VNOM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 30, 2021
Molina Healthcare's (MOH) Q1 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter earnings gain from higher revenues and increased membership in Medicaid and Marketplace.
Tenet (THC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Humana's (HUM) Q1 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) Q1 earnings gain from better revenues and a solid contribution by its Retail segment.
Why Fast-paced Mover Tenet (THC) Is a Great Choice for Value Investors
by Zacks Equity Research
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.